Published in Immunology on April 01, 2001
Perspectives on clinical and preclinical testing of new tuberculosis vaccines. Clin Microbiol Rev (2010) 1.13
Expression of L-Selectin (CD62L), CD44, and CD25 on activated bovine T cells. Infect Immun (2003) 0.95
A spotlight on liquefaction: evidence from clinical settings and experimental models in tuberculosis. Clin Dev Immunol (2011) 0.86
Transcript levels of major interleukins in relation to the clinicopathological profile of patients with tuberculous intervertebral discs and healthy controls. PLoS One (2014) 0.77
Correlation between Serum Level of Monocyte Chemoattractant Protein-1 and Postoperative Recurrence of Spinal Tuberculosis in the Chinese Han Population. PLoS One (2015) 0.77
Perspectives for Developing New Tuberculosis Vaccines Derived from the Pathogenesis of Tuberculosis: I. Basic Principles, II. Preclinical Testing, and III. Clinical Testing. Vaccines (Basel) (2013) 0.75
BCG-induced rabbit alveolar macrophages are endowed with strengthened antioxidant metabolic pathways. Inflammation (2007) 0.75
Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest (1998) 13.05
Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science (1991) 5.76
Mature T lymphocyte apoptosis--immune regulation in a dynamic and unpredictable antigenic environment. Annu Rev Immunol (1999) 4.97
C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science (1996) 4.35
Interleukin-1 receptor antagonist: role in biology. Annu Rev Immunol (1998) 3.78
Mycobacterium. Bacteriol Rev (1977) 3.20
Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation. Am J Pathol (1997) 2.47
Control of immune pathology by regulatory T cells. Curr Opin Immunol (1998) 2.42
Modulation of immune complex-induced inflammation in vivo by the coordinate expression of activation and inhibitory Fc receptors. J Exp Med (1999) 2.23
Bacterial perturbation of cytokine networks. Infect Immun (1998) 1.96
Immune and inflammatory processes in cutaneous tissues. Mechanisms and speculations. J Clin Invest (1990) 1.85
Serum therapy for tuberculosis revisited: reappraisal of the role of antibody-mediated immunity against Mycobacterium tuberculosis. Clin Microbiol Rev (1998) 1.82
A mycobacterial 65-kD heat shock protein induces antigen-specific suppression of adjuvant arthritis, but is not itself arthritogenic. J Exp Med (1990) 1.75
Cavitary tuberculosis produced in rabbits by aerosolized virulent tubercle bacilli. Infect Immun (1996) 1.68
Initial cytokine exposure determines function of macrophages and renders them unresponsive to other cytokines. J Immunol (1998) 1.57
Human humoral responses to antigens of Mycobacterium tuberculosis: immunodominance of high-molecular-mass antigens. Clin Diagn Lab Immunol (1997) 1.43
Paradox of the global emergency of tuberculosis. Lancet (1999) 1.42
Soluble receptors in human disease. J Leukoc Biol (1998) 1.38
Delineation of human antibody responses to culture filtrate antigens of Mycobacterium tuberculosis. J Infect Dis (1998) 1.36
Leukotriene B4. Int J Biochem Cell Biol (1998) 1.28
Roles of cytotoxic delayed-type hypersensitivity and macrophage-activating cell-mediated immunity in the pathogenesis of tuberculosis. Immunobiology (1994) 1.25
IL-6: insights into novel biological activities. Clin Immunol Immunopathol (1997) 1.24
Adenosine - cyclic AMP pathways and cytokine expression. Eur Cytokine Netw (1999) 1.24
Analysis of T cells recruited during delayed-type hypersensitivity to purified protein derivative (PPD) versus challenge with tuberculosis infection. Immunology (1998) 1.24
Immunologic interactions of T lymphocytes with vascular endothelium. Adv Immunol (1991) 1.22
Selective inhibition of expression of the chemokine receptor CCR2 in human monocytes by IFN-gamma. J Immunol (1998) 1.11
Neutrophil attractant/activation protein-1 and monocyte chemoattractant protein-1 in rabbit. cDNA cloning and their expression in spleen cells. J Immunol (1991) 1.09
The interleukin-1 axis and cutaneous inflammation. J Invest Dermatol (1995) 1.08
E-selectin mediates leukocyte rolling in interleukin-1-treated rabbit mesentery venules. Blood (1994) 1.05
Human mast cells produce the CD4+ T lymphocyte chemoattractant factor, IL-16. J Immunol (1997) 1.05
Increased expression in vivo of VCAM-1 and E-selectin by the aortic endothelium of normolipemic and hyperlipemic diabetic rabbits. Arterioscler Thromb (1994) 1.05
Failure of passive serum transfer of immunity against aerogenic tuberculosis in rabbits. Proc Soc Exp Biol Med (1974) 1.02
Inducible nitric oxide: an autoregulatory feedback inhibitor of vascular inflammation. J Immunol (1998) 1.00
Endothelial adhesion molecules in health and disease. Pathol Biol (Paris) (1998) 0.98
Origin and characteristics of ultraviolet-B radiation-induced suppressor T lymphocytes. J Immunol (1998) 0.97
IL-12 is a heparin-binding cytokine. J Immunol (1999) 0.97
Cell-to-cell and cell-to-matrix interactions mediate chemokine expression: an important component of the inflammatory lesion. J Leukoc Biol (1997) 0.97
Macrophage functional heterogeneity in vivo. Macrolocal and microlocal macrophage activation, identified by double-staining tissue sections of BCG granulomas for pairs of enzymes. Am J Pathol (1980) 0.95
Production of chemokines and proinflammatory and antiinflammatory cytokines by human alveolar macrophages activated by IgE receptors. J Allergy Clin Immunol (1999) 0.95
Altered responses of human macrophages to lipopolysaccharide by hydroperoxy eicosatetraenoic acid, hydroxy eicosatetraenoic acid, and arachidonic acid. Inhibition of tumor necrosis factor production. J Clin Invest (1997) 0.95
Cloning, expression and significance of MPT53 for identification of secreted proteins of Mycobacterium tuberculosis. Microb Pathog (1999) 0.92
Nonspecific and immune-specific up-regulation of cytokines in rabbit dermal tuberculous (BCG) lesions. J Leukoc Biol (1998) 0.91
Role of complement in in vitro and in vivo lung inflammatory reactions. J Leukoc Biol (1998) 0.91
Chemokines and chemokine receptors during activation and deactivation of monocytes and dendritic cells and in amplification of Th1 versus Th2 responses. Int J Clin Lab Res (1998) 0.90
Catecholaminergic suppression of immunocompetent cells. Immunol Today (1998) 0.90
Human mast cell cytokines. Clin Exp Allergy (1996) 0.89
von Willebrand factor and the endothelium. Mayo Clin Proc (1991) 0.89
Inhibition of IL-2 production by nitric oxide: a novel self-regulatory mechanism for Th1 cell proliferation. Immunol Cell Biol (1997) 0.89
Differential modulation of annexin I binding sites on monocytes and neutrophils. Mediators Inflamm (1999) 0.88
Cellular adhesion and its antagonism. J Allergy Clin Immunol (1997) 0.87
In situ expression of cytokines and cellular phenotypes in the lungs of mice with slowly progressive primary tuberculosis. Scand J Immunol (2000) 0.86
The cytokines NAP-1 (IL-8), MCP-1, IL-1 beta, and GRO in rabbit inflammatory skin lesions produced by the chemical irritant sulfur mustard. Inflammation (1996) 0.84
High-affinity immunoglobulin E receptor (Fc epsilon RI)-bearing eosinophils, mast cells, macrophages and Langerhans' cells in allergen-induced late-phase cutaneous reactions in atopic subjects. Immunology (1998) 0.84
Role of C3a and C5a in the activation of mast cells. Exp Clin Immunogenet (1997) 0.83
The pattern of mycobacterial antigen recognition in sera from Mantoux-negative individuals is essentially unaffected by bacille Calmette-Guérin (BCG) vaccination in either south India or London. Clin Exp Immunol (1992) 0.81
Longitudinal trends in serum levels of mycobacterial secretory (30 kD) and cytoplasmic (65 kD) antigens during chemotherapy of pulmonary tuberculosis patients. Scand J Infect Dis (1998) 0.79
Rabbit vascular endothelial adhesion molecules: ELAM-1 is most elevated in acute inflammation, whereas VCAM-1 and ICAM-1 predominate in chronic inflammation. J Leukoc Biol (1996) 0.79
Antiinflammatory potential of lipoxygenase-derived eicosanoids: a molecular switch at 5 and 15 positions? J Clin Invest (1997) 0.78
Cellular hypersensitivity and cellular immunity in the pathogensis of tuberculosis: specificity, systemic and local nature, and associated macrophage enzymes. Bacteriol Rev (1968) 4.25
Vaccination against tuberculosis by DNA injection. Nat Med (1996) 3.76
IS6110 restriction fragment length polymorphism typing of clinical isolates of Mycobacterium tuberculosis from patients with pulmonary tuberculosis in Madras, south India. Tuber Lung Dis (1995) 3.76
Effect of ultraviolet radiation on cataract formation. N Engl J Med (1988) 3.59
Phagolysosome formation, cyclic adenosine 3':5'-monophosphate and the fate of Salmonella typhimurium within mouse peritoneal macrophages. J Gen Microbiol (1979) 3.18
Homology between mammalian cell DNA sequences and human herpesvirus genomes detected by a hybridization procedure with high-complexity probe. Cell (1982) 3.06
The local nature of immunity in tuberculosis, illustrated histochemically in dermal BCG lesions. J Immunol (1968) 2.71
Killing of Mycobacterium microti by immunologically activated macrophages. Nature (1981) 2.62
Virulence and resistance to superoxide, low pH and hydrogen peroxide among strains of Mycobacterium tuberculosis. J Gen Microbiol (1978) 2.58
Food Allergy Herbal Formula-1 (FAHF-1) blocks peanut-induced anaphylaxis in a murine model. J Allergy Clin Immunol (2001) 2.51
Effects of some factors on neonatal and postneonatal mortality. Analysis by a binary variable multiple regression method. Milbank Mem Fund Q (1971) 2.29
Viral etiology of juvenile- and adult-onset squamous papilloma of the larynx. Proc Natl Acad Sci U S A (1982) 2.11
Isolation and restriction endonuclease analysis of mycobacterial DNA. J Gen Microbiol (1986) 2.11
Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors. Am J Pathol (2001) 2.06
Nuclear mitochondria? Science (1965) 2.05
Application of DNA fingerprinting with IS986 to sequential mycobacterial isolates obtained from pulmonary tuberculosis patients in Hong Kong before, during and after short-course chemotherapy. Tuber Lung Dis (1993) 1.94
The chinese herbal medicine formula MSSM-002 suppresses allergic airway hyperreactivity and modulates TH1/TH2 responses in a murine model of allergic asthma. J Allergy Clin Immunol (2000) 1.89
Non-A, non-B post-transfusion hepatitis. Looking back in the second decade. Ann Intern Med (1993) 1.89
Clinicopathologic analysis of patients with adult rhabdomyosarcoma. Cancer (2001) 1.86
A murine model of peanut anaphylaxis: T- and B-cell responses to a major peanut allergen mimic human responses. J Allergy Clin Immunol (2000) 1.84
The normal range--a common misuse. J Chronic Dis (1967) 1.78
Low birth weight and neonatal mortality rate related to maternal smoking and socioeconomic status. Am J Obstet Gynecol (1971) 1.73
Pathogenesis of pulmonary tuberculosis. Am Rev Respir Dis (1982) 1.73
A murine model of IgE-mediated cow's milk hypersensitivity. J Allergy Clin Immunol (1999) 1.73
Macrophage proteinase and inflammation: the production of chemotactic activity from the fifth complement by macrophage proteinase. J Immunol (1972) 1.71
Cavitary tuberculosis produced in rabbits by aerosolized virulent tubercle bacilli. Infect Immun (1996) 1.68
Identification and characterization of protective T cells in hsp65 DNA-vaccinated and Mycobacterium tuberculosis-infected mice. Infect Immun (1998) 1.64
Sarcoidosis presenting as bilateral hydronephrosis. Intern Med (1996) 1.63
Müller muscle-conjunctiva resection. Technique for treatment of blepharoptosis. Arch Ophthalmol (1975) 1.60
Pathogenesis of experimental tuberculosis in animal models. Curr Top Microbiol Immunol (1996) 1.57
Phagosome-lysosome fusion and cyclic adenosine 3':5'-monophosphate in macrophages infected with Mycobacterium microti, Mycobacterium bovis BCG or Mycobacterium lepraemurium. J Gen Microbiol (1979) 1.57
Epidemiology of sarcoidosis in Japan. Eur Respir J (2007) 1.54
Mycobacterium microti may protect itself from intracellular destruction by releasing cyclic AMP into phagosomes. Nature (1975) 1.52
Experimental autoimmune myocarditis in A/J mice is an interleukin-4-dependent disease with a Th2 phenotype. Am J Pathol (2001) 1.52
Strains of Mycobacterium tuberculosis differ in susceptibility to reactive nitrogen intermediates in vitro. Infect Immun (1994) 1.51
Virulence of Mycobacterium tuberculosis CDC1551 and H37Rv in rabbits evaluated by Lurie's pulmonary tubercle count method. Infect Immun (1999) 1.46
Protection against tuberculosis by passive transfer with T-cell clones recognizing mycobacterial heat-shock protein 65. Immunology (1994) 1.46
Achondroplasia--a genetic and statistical survey. Ann Hum Genet (1970) 1.42
Interleukin-4 receptor blockade prevents airway responses induced by antigen challenge in mice. Am J Physiol (1997) 1.42
Prevalence of asthma and health service utilization of asthmatic children in an inner city. J Allergy Clin Immunol (1982) 1.41
Nonsurgical management of blow-out fractures of the orbital floor. Am J Ophthalmol (1974) 1.41
Distribution of endogenous and exogenous carnitine in rats with sepsis and acute liver failure. Clin Nutr (1996) 1.40
A single mycobacterial protein (hsp 65) expressed by a transgenic antigen-presenting cell vaccinates mice against tuberculosis. Immunology (1994) 1.39
Hydrogen peroxide and superoxide release by alveolar macrophages from normal and BCG-vaccinated guinea-pigs after intravenous challenge with Mycobacterium tuberculosis. Br J Exp Pathol (1981) 1.39
HLA typing in the Hong Kong Chest Service/British Medical Research Council study of factors associated with the breakdown to active tuberculosis of inactive pulmonary lesions. Am Rev Respir Dis (1988) 1.38
Hürthle cell carcinoma: a critical histopathologic appraisal. J Clin Oncol (2001) 1.37
Macrophage antimycobacterial mechanisms. Br Med Bull (1988) 1.36
Secretion of a macrophage-activating factor distinct from interferon-gamma by human T cell clones. Eur J Immunol (1984) 1.33
Macrophage accumulation, division, maturation, and digestive and microbicidal capacities in tuberculous lesions. IV. Macrophage turnover, lysosomal enzymes, and division in healing lesions. Lab Invest (1972) 1.30
Formation of virus-like particles by bone cells in mice with a high incidence of spontaneous leukemia. Science (1970) 1.30
Association of nonmelanoma skin cancer and actinic keratosis with cumulative solar ultraviolet exposure in Maryland watermen. Cancer (1990) 1.29
Demonstration of papillomavirus capsid antigen in human conjunctival neoplasia. Arch Ophthalmol (1986) 1.28
Association of human papillomavirus subtype and clinical course in respiratory papillomatosis. Laryngoscope (1984) 1.25
Mucosal IFN-gamma gene transfer inhibits pulmonary allergic responses in mice. J Immunol (1996) 1.25
The effect of gamma-interferon during Mycobacterium bovis (BCG) infection in athymic and euthymic mice. Microb Pathog (1986) 1.22
Enzyme histochemistry of bone and cartilage cells. Prog Histochem Cytochem (1976) 1.21
Medications and diagnoses in relation to falls in a long-term care facility. J Am Geriatr Soc (1987) 1.20
Transforming activity of E5a protein of human papillomavirus type 6 in NIH 3T3 and C127 cells. J Virol (1990) 1.20
Characterization of T cells that confer a high degree of protective immunity against tuberculosis in mice after vaccination with tumor cells expressing mycobacterial hsp65. Infect Immun (1996) 1.20
The genetics of specific reading disability. Ann Hum Genet (1976) 1.19
Division and death rates of Salmonella typhimurium inside macrophages: use of penicillin as a probe. J Gen Microbiol (1979) 1.19
Hashimoto's disease. A clinicopathological study with matched controls. Lack of significant associations with other "autoimmune" disorders. Lancet (1965) 1.17
Localization of eosinophils to airway nerves and effect on neuronal M2 muscarinic receptor function. Am J Physiol (1997) 1.17
Survey of adolescent drug use. 3. Correlations among use of drugs. Am J Public Health (1972) 1.17
Induction of pulmonary allergic responses by antigen-specific Th2 cells. J Immunol (1998) 1.14
Characterization of distribution of T lymphocyte subsets and activated T lymphocytes infiltrating into sarcoid lesions. Intern Med (1995) 1.13
Effects of recombinant interferon-gamma and chemotherapy with isoniazid and rifampicin on infections of mouse peritoneal macrophages with Listeria monocytogenes and Mycobacterium microti in vitro. Br J Exp Pathol (1986) 1.12
How macrophages kill tubercle bacilli. J Med Microbiol (1983) 1.11
Macrophage Function in Infectious Disease with Inbred Rabbits. Bacteriol Rev (1965) 1.11
Pathogenesis of skin lesions caused by sulfur mustard. Fundam Appl Toxicol (1984) 1.10
Risk factors associated with falls and injuries among elderly institutionalized persons. Am J Epidemiol (1991) 1.10
Ultrastructure and lysosomal histochemistry of ia rat osteoclasts. Calcif Tissue Res (1974) 1.09
Identification and characterization of murine cytotoxic T cells that kill Mycobacterium tuberculosis. Infect Immun (2000) 1.09
Liquefaction of caseous foci in tuberculosis. Am Rev Respir Dis (1976) 1.09
The susceptibility of strains of Mycobacterium tuberculosis to catalase-mediated peroxidative killing. J Gen Microbiol (1980) 1.08
CpG oligodeoxynucleotides can reverse Th2-associated allergic airway responses and alter the B7.1/B7.2 expression in a murine model of asthma. J Immunol (2000) 1.08
Pulmonary bovine-type tuberculosis in rabbits: bacillary virulence, inhaled dose effects, tuberculin sensitivity, and Mycobacterium vaccae immunotherapy. Clin Diagn Lab Immunol (1998) 1.07
Survey of adolescent drug use. II. Social and environmental factors. Am J Public Health (1972) 1.07
Demonstration of increased anti-mycobacterial activity in peripheral blood monocytes after BCG vaccination in British school children. Clin Exp Immunol (1988) 1.05
Serologic precursors of cancer. Retinol, carotenoids, and tocopherol and risk of prostate cancer. J Natl Cancer Inst (1990) 1.05
Recombinant interferon-gamma and chemotherapy with isoniazid and rifampicin in experimental murine tuberculosis. Br J Exp Pathol (1986) 1.05
The role of cathepsin D in the pathogenesis of tuberculosis. A histochemical study employing unlabeled antibodies and the peroxidase-antiperoxidase complex. Am J Pathol (1974) 1.05
The familial component in longevity. A study of offspring of nonagenarians. II. Preliminary analysis of the completed study. Johns Hopkins Med J (1974) 1.04
Desmoid tumors of the head and neck--a clinical study of a rare entity. Head Neck (2000) 1.04
Electron microscopic localization of hydrolytic enzymes in osteoclasts. Histochem J (1972) 1.03
Radiation, infection, and macrophage function. II. Effect of whole body radiation on the number of pulmonary alveolar macrophages and their levels of hydrolytic enzymes. J Reticuloendothel Soc (1970) 1.02
Sites of predilection in recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol (1993) 1.02
Guinea-pig alveolar macrophages kill Mycobacterium tuberculosis in vitro, but killing is independent of susceptibility to hydrogen peroxide or triggering of the respiratory burst. Microb Pathog (1991) 1.02
Radiation, infection, and macrophage function. I. Effects of whole body radiation on dermal tuberculous lesions in rabbits: development, histology, and histochemistry. J Reticuloendothel Soc (1970) 1.02
Macrophages in immunity to syphilis: suppressive effect of concurrent infection with Mycobacterium bovis BCG on the development of syphilitic lesions and growth of Treponema pallidum in tuberculin-positive rabbits. Infect Immun (1979) 1.01
Hydrolases of rabbit macrophages. 3. Effect of BCG vaccination, tissue culture, and ingested tubercle bacilli. Proc Soc Exp Biol Med (1965) 1.01
Virulence of Mycobacterium tuberculosis and susceptibility to peroxidative killing systems. J Gen Microbiol (1978) 1.01
Respiratory papillomatosis: etiological relation to genital tract papillomaviruses. Prog Med Virol (1984) 1.01